What We're Reading: Page 72
Industry reads hand-picked by our editors
Oct 25, 2023
-
Bloomberg
Lululemon Founder Chip Wilson Races to Find Muscular Dystrophy Cure
-
Nature
An AI revolution is brewing in medicine. What will it look like?
-
Healthcare Dive
Blue Shield of California is promising a simpler, cheaper pharmacy benefits model. Can it deliver?
-
MedTech Dive
Thermo Fisher cuts 2023 forecast, citing volatile economic conditions
Oct 24, 2023
-
FirstWord Pharma
Documents reveal Mirati rebuffed $140 per share offer from BMS
-
The Wall Street Journal
Ozempic Maker Novo Nordisk Has a Weight Problem
-
NPR
Why drug shortages continue and how one woman is fighting back
-
Gizmodo
Microsoft Fixes Excel Feature That Forced Scientists to Rename Human Genes
Oct 23, 2023
Oct 20, 2023
-
Bloomberg
Jazz Pharmaceuticals Said to Explore Options Including Sale
-
Boston Business Journal
More Massachusetts biotech startups are shutting down
-
Reuters
China formally arrests Astellas employee suspected of spying, Japan urges release
-
Wired
This Vaccine Protects Against Cancer—but Not Enough Boys Are Getting It
Oct 19, 2023
Oct 18, 2023
Oct 17, 2023
-
Bloomberg Law
State Drug Pricing Boards Tee Up New Front in Pharma Legal Fight
-
Fierce Biotech
Gilead pays $100M for first dibs on all Assembly Bio assets
-
MedTech Dive
Thermo Fisher buys Olink Holding for $3.1B, pushing further into proteomics
-
The New York Times
Fight Over Covid Lab Leak Stalls Virology Research
Previous
